TORC1 Is Essential for NF1-Associated Malignancies

@article{Johannessen2008TORC1IE,
  title={TORC1 Is Essential for NF1-Associated Malignancies},
  author={Cory M. Johannessen and Bryan W. Johnson and Sybil M. Genther Williams and Annie W.-Y. Chan and Elizabeth E. Reczek and Ryan C. Lynch and Matthew J. Rioth and Andrea I McClatchey and Sandra W. Ryeom and Karen Cichowski},
  journal={Current Biology},
  year={2008},
  volume={18},
  pages={56-62}
}
Inactivating mutations in NF1 underlie the prevalent familial cancer syndrome neurofibromatosis type 1 [1]. The NF1-encoded protein is a Ras GTPase-activating protein (RasGAP) [2]. Accordingly, Ras is aberrantly activated in NF1-deficient tumors; however, it is unknown which effector pathways critically function in tumor development. Here we provide in vivo evidence that TORC1/mTOR activity is essential for tumorigenesis. Specifically, we show that the mTOR inhibitor rapamycin potently… CONTINUE READING
76 Citations
28 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 76 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1

  • S. M. Huson, R. Towers, M. Gleeson, C. Steiger
  • J . Med . Genet .
  • 2007

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: A randomised controlled trial

  • G. D. Demetri, A. T. van Oosterom, +8 authors J.A
  • Lancet
  • 2006
1 Excerpt

Similar Papers

Loading similar papers…